ArticleFrontiers in endocrinology2026
Postoperative delayed hyponatremia after endoscopic transsphenoidal surgery for pituitary adenomas: role of fluid restriction and associated risk factors.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Delayed postoperative hyponatremia remains a frequent complication after endoscopic endonasal transsphenoidal surgery (EETS) for pituitary adenomas and is a major cause of hospital readmission. Although fluid restriction has emerged as a potential preventive strategy, evidence regarding its efficacy and associated predictive factors remains limited. This study aimed to evaluate the impact of a standardized postoperative fluid-restriction protocol on the incidence of postoperative delayed hyponatremia and to identify factors associated with postoperative delayed hyponatremia development. Methods: A retrospective cohort study was conducted including 222 patients who underwent EETS for pituitary adenomas between January 2025 and January 2026. Patients with preoperative diabetes insipidus or requiring postoperative desmopressin treatment were excluded. Patients treated before implementation of routine postoperative fluid restriction constituted the non-fluid-restricted group (n=120), whereas patients treated after protocol implementation received fluid restriction of 1000 mL/day for 7 postoperative days (n=102). Delayed postoperative hyponatremia was defined as serum sodium <135 mmol/L occurring after postoperative day 3. Clinical, radiological, endocrine, and biochemical variables were analyzed. Results: Delayed postoperative hyponatremia developed in 30 patients (13.5%). The incidence was significantly lower in the fluid-restricted group than in the non-fluid-restricted group (6.9% vs 19.2%, p=0.013). Mean onset of delayed postoperative hyponatremia was postoperative day 7.9, and 93.3% of affected patients required readmission. Delayed postoperative hyponatremia development showed no significant association with age (p=0.963), sex (p=0.810), body mass index (p=0.446), tumor diameter (p=0.505), Knosp grade (p=0.350), extent of resection (p=0.289), adenoma subtype (p=0.267), or remission status (p=0.735). In contrast, suprasellar extension (p=0.010), postoperative pituitary hormone deficiency (p=0.001), preoperative hypothyroidism (p=0.033), diaphragma sellae descent (p<0.001), lumbar drainage (p<0.001), and sodium decline ≥3 mEq/L (p=0.002) were significantly associated with delayed postoperative hyponatremia. Multivariate logistic regression identified preoperative comorbidities (p=0.002), postoperative diaphragma sellae descent (p=0.029), postoperative hypothyroidism (p=0.011), postoperative hypokalemia (p=0.002), and longer hospital stay (p<0.001) as independent predictors of delayed postoperative hyponatremia. Conclusions: Routine postoperative fluid restriction significantly reduced the incidence of delayed postoperative hyponatremia following EETS for pituitary adenomas. Early postoperative sodium changes and selected perioperative factors may help identify high-risk patients and improve postoperative monitoring strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.